Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nexium

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

Evan Lippman joins Aileron Therapeutics

Evan Lippman joins Aileron Therapeutics Highlights of his career include a spell as executive director at AstraZeneca where he led on huge brands such as Crestor (rosuvastatin calcium) and Nexium (esomeprazole) and heading US business development

Nexium windfall lifts AZ in third quarter

Nexium windfall lifts AZ in third quarter Still to feel effects of generic competition. A delay to generic competition in the US for big-selling gastrointestinal drug Nexium helped AstraZeneca (AZ) post a healthy rise in third-quarter ... The quarter had been expected to be a tough one for AZ

Deal Watch table for April 2014

Deal Watch table for April 2014 Ranbaxy Laboratories/ Sun Pharmaceuticals. Acquisition. Generics including Lipitor, Nexium, Diovan. 3, 200.

Pharma deals during April 2014

Pharma deals during April 2014 this effort is Ranbaxy's new product pipeline, including generic versions of 2 blockbuster drugs: the first-to-file status for Nexium, AstraZeneca's heartburn drug, which comes off patent next

Pfizer rumoured to be after AstraZeneca

Pfizer rumoured to be after AstraZeneca Meanwhile, Pfizer has started to emerge from a patent cliff while AZ is still facing expirations on key earners such as gastrointestinal therapy Nexium (esomeprazole) and cholesterol-lowerer Crestor (rosuvastatin).

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics